Epstein Secrets

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

TED: BLOOD (k FEMORA!) (%ilAll iE :F.) _CAVITY LI I• _ SUBDURAL U OTHER i (-1(4 6 ,3 BRAIN L., VER U DECOMP U OTHER: B LE URINE TRI CONTE FLUID t ' CIPAL.. Id irrOsfA iTREOUS Na K a ._! VUN/Cr CHEMISTRY REQUEST Glucose Other: BRIEFCASE DETAILS 3itk f tntAl o ljAk VN DURAT

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

0.0 BLOOD FEMORAL) THE 3 L CAVITY • U SUBDURAL L OTHER Lit• i(44 q;4 6 , _ BRAIN J VER U DECOMP U OTHER: a FLUID 8 LE RINE RI CONTE 7REous) a U CHEMISTRY REQUEST VUN/Cr Glucose Other: NS K 1) BRIEF Eli AILS CAMV1/11 6 0 141\1"‘ (1/21,112, Atlitel . DURATION OF HOSPITA

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n

4:( co4 I BLOOD 4 FEMORAL 6eillArd U CAVITV • LJ SUBDURAL U OTHER —3 Lit ici 6 B LE ' URINE TR 4~*BRAIN VER U DECOMP U OTHER: . CONTE FLUID 1.- ijT loUs ot..0 CLL . Na K - IttSE CI U CHEMISTRY REQUEST. VUN/Cr Mucosa . •Va. cl AILS e u " a u we i vv\ : k2t/W, DURATIO